Reading Time: 4 minutesIt’s official. The FDA has announced that the shortage of GLP-1 medications like semaglutide and tirzepatide is over — and that means compounded versions of these drugs are going away for good. ➡️ Compounded semaglutide will no longer be available after May 22nd, 2025 ➡️ Compounded tirzepatide will no longer be available after March 19th, 2025 If…
Read More